These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 11002275)

  • 21. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
    Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection, identification and quantification of a new de-fluorinated impurity in casopitant mesylate drug substance during late phase development: an analytical challenge involving a multidisciplinary approach.
    Turco L; Provera S; Curcuruto O; Bernabè E; Nicoletti A; Martini L; Castoldi D; Cimarosti Z; Papini D; Marchioro C; Dams R
    J Pharm Biomed Anal; 2011 Jan; 54(1):67-73. PubMed ID: 20813481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrafast liquid chromatography/ultraviolet and liquid chromatography/tandem mass spectrometric analysis.
    Cheng Y; Lu Z; Neue U
    Rapid Commun Mass Spectrom; 2001; 15(2):141-51. PubMed ID: 11180543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking.
    Young BL; Cooks RG; Madden MC; Bair M; Jia J; Aubry AF; Miller SA
    J Pharm Biomed Anal; 2007 Apr; 43(5):1602-8. PubMed ID: 17298872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput chiral liquid chromatography/tandem mass spectrometry.
    Bakhtiar R; Tse FL
    Rapid Commun Mass Spectrom; 2000; 14(13):1128-35. PubMed ID: 10867688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery.
    Chen G; Pramanik BN; Liu YH; Mirza UA
    J Mass Spectrom; 2007 Mar; 42(3):279-87. PubMed ID: 17295416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
    Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
    J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of recent applications of inductively coupled plasma-mass spectrometry (ICP-MS) in determination of inorganic impurities in drugs and pharmaceuticals.
    Nageswara Rao R; Talluri MV
    J Pharm Biomed Anal; 2007 Jan; 43(1):1-13. PubMed ID: 16891084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
    Pan C; Harmon F; Toscano K; Liu F; Vivilecchia R
    J Pharm Biomed Anal; 2008 Feb; 46(3):520-7. PubMed ID: 18180126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Principles and applications of LC-MS in new drug discovery.
    Korfmacher WA
    Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS.
    Halket JM; Waterman D; Przyborowska AM; Patel RK; Fraser PD; Bramley PM
    J Exp Bot; 2005 Jan; 56(410):219-43. PubMed ID: 15618298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
    Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
    J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of liquid chromatography/tandem mass spectrometric molecular fingerprinting for the rapid structural identification of pharmaceutical impurities.
    Li M; Wang X; Chen B; Lin M; Buevich AV; Chan TM; Rustum AM
    Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3533-42. PubMed ID: 19844969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals.
    Nageswara Rao R; Nagaraju D; Alvi SN; Bhirud SB
    J Pharm Biomed Anal; 2004 Nov; 36(4):759-67. PubMed ID: 15533668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
    Xue YJ; Akinsanya JB; Liu J; Unger SE
    Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater.
    Bueno MJ; Agüera A; Gómez MJ; Hernando MD; García-Reyes JF; Fernandez-Alba AR
    Anal Chem; 2007 Dec; 79(24):9372-84. PubMed ID: 18001124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials.
    Gavin PF; Olsen BA; Wirth DD; Lorenz KT
    J Pharm Biomed Anal; 2006 Jun; 41(4):1251-9. PubMed ID: 16621411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.